Marshall Wace, LLP Emergent Bio Solutions Inc. Transaction History
Marshall Wace, LLP
- $74.4 Billion
- Q1 2025
A detailed history of Marshall Wace, LLP transactions in Emergent Bio Solutions Inc. stock. As of the latest transaction made, Marshall Wace, LLP holds 1,157,862 shares of EBS stock, worth $8.45 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
1,157,862
Previous 1,328,641
12.85%
Holding current value
$8.45 Million
Previous $12.7 Million
55.7%
% of portfolio
0.01%
Previous 0.02%
Shares
18 transactions
Others Institutions Holding EBS
# of Institutions
176Shares Held
38MCall Options Held
94.1KPut Options Held
153K-
Black Rock Inc. New York, NY3.84MShares$28 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.21MShares$23.5 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny2.5MShares$18.3 Million0.01% of portfolio
-
American Century Companies Inc Kansas City, MO2.3MShares$16.8 Million0.01% of portfolio
-
State Street Corp Boston, MA1.71MShares$12.5 Million0.0% of portfolio
About Emergent BioSolutions Inc.
- Ticker EBS
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 49,861,500
- Market Cap $364M
- Description
- Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...